Beyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes.
Saved in:
| Title: | Beyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes. |
|---|---|
| Authors: | Taha OS; Department of Clinical Biochemistry, School of Medicine Cellular & Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran., Azami G; Department of Emergency Medical Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran., Saed L; Department of Endocrinology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran., Hakhamaneshi MS; Department of Clinical Biochemistry, School of Medicine Cellular & Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. biohakha@gmail.com., Moridi H; Department of Laboratory Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran. hereshmoridi@yahoo.com. |
| Source: | BMC endocrine disorders [BMC Endocr Disord] 2026 May 23; Vol. 26 (1). Date of Electronic Publication: 2026 May 23. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823 (Electronic) Linking ISSN: 14726823 NLM ISO Abbreviation: BMC Endocr Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
